Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitors. (Q38107072)

29 August 2017

Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837635&resulttype=core&format=json

12 May 2020

0 references

0 references

Giuseppe Murdaca

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837635&resulttype=core&format=json

12 May 2020

Francesca Spanò

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837635&resulttype=core&format=json

12 May 2020

Paola Cagnati

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837635&resulttype=core&format=json

12 May 2020

Francesco Puppo

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837635&resulttype=core&format=json

12 May 2020

publication date

10 May 2013

1 reference

29 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837635&resulttype=core&format=json

12 May 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837635&resulttype=core&format=json

12 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837635&resulttype=core&format=json

12 May 2020

page(s)

95-99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837635&resulttype=core&format=json

Endothelial dysfunction in rheumatic autoimmune diseases

12 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Endothelial function, inflammation, and prognosis in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Nitric oxide and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Progress and challenges in translating the biology of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

The immune system in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Innate immune signals in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Macrophage death and defective inflammation resolution in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Atherosclerosis: current pathogenesis and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Altered structure of autoantigens during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Dendritic cells in atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Autoimmunity in atherosclerosis: a protective response losing control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Autoimmune and inflammatory mechanisms in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Adalimumab for the treatment of immune-mediated diseases: an update on old and recent indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Anti-tumor necrosis factor-α treatment with infliximab for disseminated granuloma annulare.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Selective TNF-α inhibitor-induced injection site reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Postmenopausal changes in serum cytokine levels and hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Antibody therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Emerging biologic drugs for the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

The benefit/risk profile of TNF-blocking agents: findings of a consensus panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Chronic tumor necrosis factor-alpha inhibition enhances NO modulation of vascular function in estrogen-deficient rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

The effect of tumor necrosis factor-α antagonists on arterial stiffness in rheumatoid arthritis: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Vascular effects of biologic agents in RA and spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Elevated Levels of Interleukin-6 in Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Free Hemoglobin: A Dangerous Signal for the Immune System in Patients with Carotid Atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000213Y.0000000046

Beta2-glycoprotein I is a target of T cell reactivity in patients with advanced carotid atherosclerotic plaques

21 January 2018

1 reference

12 December 2020

Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction

1 reference

12 December 2020

Serum vascular endothelial growth factor in allergic rhinitis and systemic lupus erythematosus

1 reference

12 December 2020

Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients

1 reference

12 December 2020

Will autoantibodies help to determine severity and progression of atherosclerosis?

1 reference

12 December 2020

Oxidation of beta2-glycoprotein I (beta2GPI) by the hydroxyl radical alters phospholipid binding and modulates recognition by anti-beta2GPI autoantibodies.

1 reference

12 December 2020

Determination of lymphotoxin-alpha levels in patients with psoriatic arthritis undergoing etanercept treatment

1 reference

12 December 2020

Update upon efficacy and safety of TNF-α inhibitors

1 reference

12 December 2020

Effects of TNF-α inhibitors upon the mechanisms of action of VEGF

1 reference

12 December 2020

Serum vascular endothelial growth factor and sublingual immunotherapy

1 reference

12 December 2020

Induction of T-cell activation by oxidized low density lipoprotein

1 reference

12 December 2020

Clinical use of anti-TNF-alpha biological agents--a guide for GPs.

1 reference

12 December 2020

Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events

1 reference

12 December 2020

Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells

1 reference

12 December 2020

10.1179/1351000213Y.0000000046

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837635&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837635&resulttype=core&format=json

12 May 2020

1 reference